摘要
目的研究miR-150*修饰对骨髓间充质干细胞来源的囊泡(exosome)对胶质瘤细胞的影响。方法 qRT-PCR检测miR-150*在胶质母细胞瘤组织与正常组织间的表达量差异。培养骨髓间充质干细胞(BMSCs),分别转染miR-150*模拟物和阴性对照序列,上调BMSCs中miR-150*表达水平,提取BMSCs培养基中的exosome。Western blot验证exosomal的表面标记蛋白CD63和flotillin-1,电镜下观察exosome的形态。CCK-8和细胞周期实验验证miR-150*修饰BMSCs来源的exosome对胶质瘤细胞的影响。结果 miR-150*在胶质母细胞瘤组织中表达明显低于正常脑组织,转染miR-150*模拟物能明显提高BMSCs来源的exosome中miR-150*的表达。miR-150*修饰BMSCs来源的exosome能有效抑制胶质瘤细胞的增殖。结论 miR-150*(miR-150的互补核苷酸序列)在胶质母细胞瘤组织中低表达,miR-150*修饰BMSCs来源的exosome对胶质瘤细胞有抗增殖的作用。因此exosome可作为一种有效的基因治疗载体。
Objective MiRNA-based therapeutics hold great promise for tumor suppression,this study was to investigate the effect of miR-150*-loaded exosomes on regulation of glioma cells proliferation and cell cycle. Methods Quantitative real-time PCR on 15 glioblastoma tissues samples and normal controls were used to confirm the miR-150*expression level. Western blotting analysis and electron microscopy were employed to test exosomal biomarkers and their morphology.Transfection assay were used to collect miR-150*-loaded exosomes from bone marrow mesenchymal stem cells( BMSCs) culture medium. CCK-8 and cell cycle assays were used to analyze miR-150*-loaded exosomes effects on glioma cells. Results Level of miR-150*expression was much lower in glioblastoma than in normal tissues. Transfection assay successfully acquired miR150*-loaded exosomes which derived from bone marrow mesenchymal stem cells( BMSCs). Furthermore,miR-150*-loaded exosomes could largely inhibited glioma cells proliferation and suppress cell cycle progression. Cell counting kit 8( CCK-8) assays also demonstrated miR-150*delivered in exosomes was much less toxic. Conclusions This study demonstrated miR-150*is down-regulated in glioblastoma. miR-150*-loaded exosomes could suppress glioma cells and exosomes may be a potentially efficient therapeutic delivery system.
出处
《临床神经外科杂志》
CAS
2015年第4期274-278,共5页
Journal of Clinical Neurosurgery
基金
无锡市医管中心重大项目基金资助项目(YGZZ1101)